TY  - GEN
AU  - Michallet,Mauricette
AU  - Socié,Gerard
AU  - Mohty,Mohamad
AU  - Sobh,Mohamad
AU  - Bay,Jacques-O
AU  - Morisset,Stéphane
AU  - Labussière-Wallet,Hélène
AU  - Tabrizi,Reza
AU  - Milpied,Noel
AU  - Bordigoni,Pierre
AU  - El-Cheikh,Jean
AU  - Blaise,Didier
TI  - Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study
SN  - 1873-2399
PY  - 2013///0419
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - etiology
KW  - Graft vs Leukemia Effect
KW  - Humans
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Peripheral Blood Stem Cell Transplantation
KW  - Prospective Studies
KW  - Rituximab
KW  - Salvage Therapy
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
KW  - Whole-Body Irradiation
KW  - adverse effects
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.exphem.2012.10.008
ER  -